logo
Hikma reiterates full year guidance following good start to the year

Hikma reiterates full year guidance following good start to the year

Web Release24-04-2025

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting.
Riad Mishlawi, Hikma's CEO, said:
'We are pleased to reiterate our Group guidance for 2025. As a global company with strong local expertise and footprint, we are leveraging our manufacturing proficiency and advanced technologies to meet the needs of our customers and patients across our markets. Looking ahead, and recognising the broader geo-political challenges, we are well-positioned. Our step up in R&D investment, alongside local manufacturing enhancements, and strategic partnerships will continue to strengthen our portfolio and pipeline and ensure sustained success.'
Injectables
Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies. We are seeing strong demand for our products across our European and MENA markets, where we continue to launch new products. In North America we are benefitting from good demand for the recently launched liraglutide injection and the contribution from the newly acquired Xellia portfolio. This is helping to offset increased competition across some of our existing higher margin products.
We expect momentum to improve in the second half driven by new product launches and contract manufacturing. We are making excellent progress in the enhancements to our Bedford, Ohio facility, which will significantly increase our US-based injectables manufacturing capacity.
We continue to expect 2025 Injectables revenue to grow in the range of 7% to 9%. Phasing and mix of sales will impact margins in the first half but we continue to expect full year core operating margin to be in the mid-30s.
Branded
Our Branded business is performing well. We continue to make good progress in building our diversified portfolio of products used to treat chronic illnesses, with a focus on oncology and lifestyle diseases, supported by our global expertise and strong local market position.
Our leading presence in the MENA region, combined with the breadth of our reach and strong commercial capabilities positions us as a partner of choice. We recently signed an exclusive licensing agreement with pharmaand GmbH, a global pharmaceutical business based in Vienna, to commercialise rucaparib, an innovative small-molecule oral oncology therapy, across the MENA region. This is in line with our strategy to be a leading provider of oncology medicines in the region.
We continue to expect 2025 Branded revenue to grow in the range of 6% to 7% in constant currency, with core EBIT margin close to 25%.
Generics
In our Generics business we are seeing solid demand across our differentiated portfolio, particularly for our nasal and inhalation products. By focusing on reliability of supply, high service levels and leveraging our US manufacturing facility, we are successfully securing longer-term customer awards.
We continue to strengthen our R&D capabilities, including building a team in our new Zagreb, Croatia R&D centre, and are progressing with key development projects that will help strengthen our portfolio and pipeline for the medium to long-term. We are progressing well preparing our Columbus facility to accommodate our recently announced contract manufacturing partnership, and we are seeing increasing demand for our high-quality US-based manufacturing services.
We continue to expect Generics revenue to be broadly flat in 2025 with core operating margin of around 16%.
International trade policies
We are confident that our significant and expanding US manufacturing footprint, which supplies the majority of our US sales, combined with our focus on quality and reliability of supply, positions us well and underpins our resilience in the current environment. We do import some finished products into the US as well as capital equipment, and we have a diversified global supply chain for our raw and packaging materials, including active pharmaceutical ingredients (API).
Full year outlook unchanged
We continue to expect Group revenue to grow in the range of 4% to 6% and for core operating profit to be in the range of $730 million to $770 million in 2025. Group core operating profit growth, which is around 4% at the midpoint of guidance, will be weighted to the second half. We are monitoring the evolving tariff backdrop and will look to remain agile in responding to both opportunities and impacts where possible, but have not reflected an impact from tariffs in our full year outlook.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UAE-Pakistan trade set to exceed $7b in 2025
UAE-Pakistan trade set to exceed $7b in 2025

Gulf Today

time8 hours ago

  • Gulf Today

UAE-Pakistan trade set to exceed $7b in 2025

The bilateral trade relations between the UAE and Pakistan are set to cross $7 billion by 2025. The UAE is a major trading partner for Pakistan, and the two countries are also working on agreements to enhance cooperation in various sectors like trade, investment, and cultural exchange. Kiran Khawaja, CEO of Dubai-based Fajar Realty, whowas recently honored as a 'Guest of Honour' in recognition of her efforts in the real estate industry at Gulf Achievers Awards stated, "I am really happy, and it is a great privilege to be recognised as 'Guest of Honour' at the award show. I am proud of the impact I have been able to make in the Emirates, and Dubai in particular, which is the major hub for international trade and investment with a booming real estate market.' Further stating Kiran revealed, 'The bilateral trade between Pakistan and the UAE exceeded $10.9 billion in the fiscal year 2023–24, including both goods and services." "While interacting with the media he also disclosed that remittances from the Pakistani community in the UAE reached $6.7 billion in 2024, and are expected to surpass $7 billion in 2025. These figures reflect not only the strength of our economic partnership, but also the vital role played by the Pakistani diaspora in supporting the national economy,' the ambassador stated.' Kiran has always been in the limelight and has won many awards and recognition in her illustrious 18-year journey. It may be recalled that Kiran has won many accolades and awards for her hard work and zeal. She walked away with 'Asia Business Outlook Top 10 Most Promising Global Leaders From Pakistan 2023' and the much-coveted 'Being She Excellence Best Real Estate Broker 2023'. Further adding to her accolades are an array of awards, with FajarRealty securing honours such as the 'DAMAC Top Performing Agency', the 'Azizi Agents Award Gala 2023', and the 'Emaar Token of Appreciation Award'. Additionally, they were given the Menaa Leadership Award for 2023 and many more. Under the leadership of Kiran, Fajar Realty has traversed a long way and has carved a niche in the world of real estate not only in Dubai but overseas as well. Recognising the immense innovation and continued growth plans for real estate in Dubai and the greater Middle East, Kiran has become immersed in Dubai's booming real estate industry for over two decades now, one of the city's most important business sectors, and hopes to bring more international investors to this city.

Dubai-based Indian karting prodigy Atiqa joins professional motorsport programme
Dubai-based Indian karting prodigy Atiqa joins professional motorsport programme

Gulf Today

time8 hours ago

  • Gulf Today

Dubai-based Indian karting prodigy Atiqa joins professional motorsport programme

Atiqa Mir, a 10-year-old Dubai-based Indian karting prodigy has become the youngest driver from the region to secure a place in a professional motorsport development programme, following her signing as an official AKCEL GP Academy driver. This landmark move signals a powerful shift in motorsport accessibility and diversity, reinforcing the UAE's commitment to nurturing next-generation talent and establishing itself as a global hub for motorsport excellence. A rising star in the karting circuit, Atiqa has already made a name for herself with her fearless driving, consistent podium finishes, and an unwavering passion for racing. She has competed in some of the world's most prestigious karting championships, including the Rotax Euro Trophy, Rotax International Trophy, IAME Series (UAE and Europe), WSK Euro Series, WSK Super Master Series, and the Champions of the Future Academy. The timing of this partnership aligns with the official launch of the AKCEL GP Academy—the cornerstone development initiative of AKCEL GP, the UAE-based high-performance motorsport team competing in FIA F4, Formula Regional Middle East Championship, and FIA F3. Opening in Abu Dhabi in August 2025, the Academy will serve as a cutting-edge training ground for the next generation of racing talent from the UAE and abroad. The Academy's inaugural batch will feature 15 promising young drivers and is committed to offering a structured and competitive pathway beginning with elite karting championships and advancing through the ranks of single-seater racing. Speaking on Atiqa's signing, Amit Kaushal, Group Chairman of AKCEL Group, said, 'Atiqa's talent, focus, and composure on track are well beyond her years. We're proud to welcome her to the AKCEL GP family and support her long-term journey toward Formula 1. Over the next 15 years, we're committed to guiding her development from karting to single-seaters as she grows into a world-class racer and future F1 contender.' As Atiqa begins her training in Abu Dhabi, she will follow a carefully structured development program designed to prepare young drivers for the demands of professional motorsport. Her training will combine simulator sessions, physical conditioning, mental coaching, race craft development, and in-depth performance analysis. A key focus of her time with AKCEL GP Academy will be competing in championships across the UAE and Europe, providing her with essential on-track experience and exposure to high-level competition early in her career. The goal is to lay a strong foundation of skills, discipline, and racecraft with a clear vision: Formula 1 as the ultimate destination. Reflecting on this new chapter in her journey, Atiqa said, 'Racing is everything to me. It's where I feel strong, fast, and free. Joining AKCEL GP Academy is a dream come true, and I want to show young girls like me from Dubai and India that we can compete at the highest levels. One day, I hope to race in Formula 1, and I'm ready to work hard to get there.' The UAE's support for motorsport development has grown rapidly over the past decade. The nation is home to internationally acclaimed circuits such as Yas Marina in Abu Dhabi and Dubai Autodrome and hosts one of the most prestigious events on the racing calendar, the Formula 1 Abu Dhabi Grand Prix.

Israel has sold record amount of debt in US since war on Gaza erupted: Report
Israel has sold record amount of debt in US since war on Gaza erupted: Report

Middle East Eye

time9 hours ago

  • Middle East Eye

Israel has sold record amount of debt in US since war on Gaza erupted: Report

Israel has sold a record amount of debt in the US since its war on Gaza erupted on 7 October 2023, according to a report by Bloomberg on Friday. The government of Israel's US-based bond broker, Israel Bonds, says it has sold $5bn worth of debt in the last twenty months. The level of bond issuance is more than double that raised by Israel Bonds, in similar time periods previously. Israel's war on Gaza started after the 7 October 2023 Hamas-led attacks on southern Israel killed around 1,200 people. Israel responded by pummelling the Gaza Strip and invading it. More than 54,000 people, mainly women and children, have been killed in the Israeli attacks, and the population is facing "imminent famine", the United Nations says. Israel Bonds is affiliated with Israel's finance ministry and sells bonds inside the US to both retail and institutional investors. The starting price for non-tradable retail Israeli bonds is as low as $36. A five-year Israeli bond has a yield between 4.86 percent and 5.44 percent, according to the Bloomberg report. New MEE newsletter: Jerusalem Dispatch Sign up to get the latest insights and analysis on Israel-Palestine, alongside Turkey Unpacked and other MEE newsletters Along with its war on Gaza, Israel fought a devastating war with Hezbollah in Lebanon and launched widespread strikes on Syria. In 2024, it engaged in two rounds of direct missile and drone attacks with Iran. Israel's financing needs have soared as it looks to fund its military. Local Israeli creditors, including deep-pocketed institutional ones, account for about 80 percent of the government's lending overall. That leaves just twenty percent to come from international debt sales and what Israel Bonds sells in the US. According to the group, local US governments at the state and county level are big buyers in places like New York, Texas, Ohio, and Illinois. Palm Beach County in Florida became one of the world's largest investors in Israeli Bonds in 2024, with about $700m of its $4.67bn portfolio invested there. Israel has faced widespread criticism for its war on Gaza. The International Criminal Court has issued an arrest warrant for Prime Minister Benjamin Netanyahu and former Defence Minister Yoav Gallant for alleged war crimes. Meanwhile, public opinion on Israel has turned sharply negative from France to Japan. However, in March 2024, Israel saw strong demand for its debt among international investors. It sold $8bn in international bonds. Israel enjoys investment-grade ratings from major credit ratings agencies.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store